Nuveen’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
Nuveen's MXCT Position: Q3 2026 in Review
Nuveen opened a new position in MaxCyte (MXCT) in Q3 2026: 9,047 shares worth $11.2K. The stake represents ﹤0.01% of the portfolio and ranks #4525 among its holdings. This is a return to the name: Nuveen previously reported a position in MXCT as recently as Q1 2026.
Nuveen first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.31M in Q4 2021. 43 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.
- Nuveen held 9,047 shares of MaxCyte worth $11.2K as of Q3 2026.
- MaxCyte was a new Nuveen position in Q3 2026.
- MaxCyte made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4525 holding.
- Nuveen first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
- Nuveen's MaxCyte position peaked at $3.31M in Q4 2021.
- 43 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.
Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.